Overview

Intravenous Subdissociative-dose Ketamine Versus Morphine for Prehospital Analgesia

Status:
Recruiting
Trial end date:
2022-05-30
Target enrollment:
Participant gender:
Summary
This is a prospective, randomized, single-blind trial evaluating prehospital patients experiencing moderate to severe acute pain, defined as a numeric rating scale score greater than or equal to 5. Patients will be randomized to receive ketamine at or morphine by intravenous push.
Phase:
Phase 3
Details
Lead Sponsor:
Nantes University Hospital
Treatments:
Ketamine
Morphine